SEPRACOR INC. Executive Retention AgreementExecutive Retention Agreement • November 9th, 2007 • Sepracor Inc /De/ • Pharmaceutical preparations • Massachusetts
THIS EXECUTIVE RETENTION AGREEMENT by and between Sepracor Inc., a Delaware corporation (the “Company”), and Mark Iwicki (the “Executive”) is made as of October 15, 2007 (the “Effective Date”).
EMPLOYMENT AGREEMENTEmployment Agreement • November 9th, 2007 • Sepracor Inc /De/ • Pharmaceutical preparations • Massachusetts
THIS EMPLOYMENT AGREEMENT (the “Agreement”), made this 15th day of October 2007, is entered into by Sepracor Inc., a Delaware corporation with its principal place of business at 84 Waterford Drive, Marlborough, Massachusetts 01752-7231 (the “Company”), and Mark Iwicki residing at 12 Bristol Terrace, Long Valley, New Jersey 07853 (the “Executive”).
DEVELOPMENT, LICENSE AND COMMERCIALIZATION AGREEMENTDevelopment, License and Commercialization Agreement • November 9th, 2007 • Sepracor Inc /De/ • Pharmaceutical preparations • New York
This DEVELOPMENT, LICENSE AND COMMERCIALIZATION AGREEMENT (“Agreement”) is entered into between Sepracor Inc., a company organized under the laws of the State of Delaware, United States, and having its principal place of business at 84 Waterford Drive, Marlborough, MA 01752-7010, United States, and Glaxo Group Limited, a company organized under the laws of England & Wales and having its principal place of business at Glaxo Wellcome House, Berkeley Avenue, Greenford, Middlesex, UB6 0NN, United Kingdom (“GSK”).
AMENDED AND RESTATED TRANSITION AND SEVERANCE AGREEMENTTransition and Severance Agreement • November 9th, 2007 • Sepracor Inc /De/ • Pharmaceutical preparations • Massachusetts
This Amended and Restated Transition and Severance Agreement (the “Agreement”) is entered into as of September 7, 2007 (the “Effective Date”), by and between Sepracor Inc. (“Sepracor” or the “Company”) and W. James O’Shea (“O’Shea”) (individually, a “Party,” and collectively, the “Parties”) and amends and restates the Transition and Severance Agreement between the Parties entered into as of March 1, 2007.
